Overview
- Dana-Farber secured a $20 million philanthropic grant from the Elaine and Eduardo Saverin Foundation to advance metastatic breast cancer research and care.
- Institute leaders said it is the largest non-federal award for metastatic breast cancer at Dana-Farber.
- Funding will optimize clinical trials and identify biomarkers of response and resistance to accelerate patient studies.
- The initiative will harness AI and integrate clinical, genomic, and imaging data from more than 20,000 patients to inform personalized therapies.
- Resources will also support liquid diagnostics for early recurrence detection and continue Saverin Research Awards for innovative investigator-led projects.